Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab
Purpose. To evaluate antiangiogenic effect of local use of bevacizumab (anti-VEGF antibody) in patients with corneal neovascularization. Methods. Patients were divided into two groups. All patients suffered from some form of corneal neovascularization (NV). Patients in group A received 0.2–0.5 mL of...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2014-01-01
|
| Colecção: | Journal of Ophthalmology |
| Acesso em linha: | http://dx.doi.org/10.1155/2014/178132 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|